Por favor, usa este identificador para citar o enlazar este ítem: http://hdl.handle.net/10668/4400
Título : Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine
Autor : Carrasco-Hernández, Laura
Quintana-Gallego, Esther
Calero, Carmen
Reinoso-Arija, Rocío
Ruiz-Duque, Borja
López-Campos, José Luis
Filiación: [Carrasco-Hernández,L; Quintana-Gallego,E; Calero,C; Reinoso-Arija,R; Ruiz-Duque,B; López-Campos,JL] Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla, Sevilla, Spain. [Carrasco-Hernández,L; Quintana-Gallego,E; Calero,C; López-Campos,JL] Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Palabras clave : Cystic fibrosis transmembrane conductance regulator;COPD;CFTR modulators;Ivacaftor;Icenticaftor;Mucociliary clearance;Mucus;Inflammation;Phosphodiesterase inhibitors;Regulador de conductancia de transmembrana de fibrosis quística;Enfermedad pulmonar obstructiva crónica;Depuración mucociliar;Moco;Inflamación;Inhibidores de fosfodiesterasa
MeSH: Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Carrier Proteins::Membrane Transport Proteins::Ion Channels::Chloride Channels::Cystic Fibrosis Transmembrane Conductance Regulator
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Techniques, Respiratory System::Mucociliary Clearance
Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Antioxidants
Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Protein S
Medical Subject Headings::Phenomena and Processes::Chemical Phenomena::Physicochemical Phenomena::Viscosity
Medical Subject Headings::Diseases::Respiratory Tract Diseases::Lung Diseases::Lung Diseases, Obstructive::Pulmonary Disease, Chronic Obstructive
Medical Subject Headings::Anatomy::Fluids and Secretions::Bodily Secretions::Mucus
Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Inflammation
Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Phosphodiesterase Inhibitors
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Fluid Therapy
Medical Subject Headings::Organisms::Bacteria
Medical Subject Headings::Organisms::Viruses
Fecha de publicación : 10-oct-2021
Editorial : MDPI
Cita Bibliográfica: Carrasco-Hernández L, Quintana-Gallego E, Calero C, Reinoso-Arija R, Ruiz-Duque B, López-Campos JL. Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine. Biomedicines. 2021 Oct 10;9(10):1437
Abstract: In recent years, numerous pathways were explored in the pathogenesis of COPD in the quest for new potential therapeutic targets for more personalised medical care. In this context, the study of the cystic fibrosis transmembrane conductance regulator (CFTR) began to gain importance, especially since the advent of the new CFTR modulators which had the potential to correct this protein's dysfunction in COPD. The CFTR is an ion transporter that regulates the hydration and viscosity of mucous secretions in the airway. Therefore, its abnormal function favours the accumulation of thicker and more viscous secretions, reduces the periciliary layer and mucociliary clearance, and produces inflammation in the airway, as a consequence of a bronchial infection by both bacteria and viruses. Identifying CFTR dysfunction in the context of COPD pathogenesis is key to fully understanding its role in the complex pathophysiology of COPD and the potential of the different therapeutic approaches proposed to overcome this dysfunction. In particular, the potential of the rehydration of mucus and the role of antioxidants and phosphodiesterase inhibitors should be discussed. Additionally, the modulatory drugs which enhance or restore decreased levels of the protein CFTR were recently described. In particular, two CFTR potentiators, ivacaftor and icenticaftor, were explored in COPD. The present review updated the pathophysiology of the complex role of CFTR in COPD and the therapeutic options which could be explored.
URI: http://hdl.handle.net/10668/4400
Versión del editor : https://www.mdpi.com/2227-9059/9/10/1437/htm
DOI: 10.3390/biomedicines9101437
ISSN : 2227-9059 (Online)
Aparece en las colecciones: 01- Artículos - Hospital Virgen del Rocío
01- Artículos - IBIS. Instituto de Biomedicina de Sevilla

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
CarrascoHernandez_DysfunctionIn.pdfRevisión1,17 MBAdobe PDFVisualizar/Abrir


Este ítem está protegido por copyright original



Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons